Építés alatt – nem éles oldal
Belépés
Toborzás még nem indultFázis nélkül

IVUS Guidance in BTK Interventions

A legfontosabb adatok

Ki végzi
Shin Kong Wu Ho-Su Memorial Hospital
Hol
Tajvan4 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
212 fő, tervezett
Kezdés
2026. aug.
Várható befejezés
2030. júl.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Intravascular ultrasound-guided EVT
  • Angiography-guided EVT
A regiszteradat frissítve
2026. július 28.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with chronic limb-threatening ischemia, very poor blood flow in the leg, who are having a procedure to open a blocked artery below the knee.

Életkor
18 years or older.
Nem
All sexes can join.
A betegség stádiuma
Chronic limb-threatening ischemia with rest pain, gangrene or a non-healing ulcer (Rutherford classes 4-5). The arteries from the aorta down to the second part of the knee artery (P2) must be open.
Korábbi kezelés
Earlier procedures to open arteries are allowed. If arteries higher up are treated in the same procedure, that treatment must work first, with less than 30% narrowing left.
Biomarker vagy leletérték
Imaging within the past 12 months showing artery disease. ABI ≤0.80 or TBI ≤0.60 if never treated before; ABI ≤0.85 or TBI ≤0.65 after earlier treatment; or low ankle, toe or skin oxygen pressures as set by the criteria.

A részvétel fő kizáró okai

  • Major tissue loss (Rutherford 6) with a major amputation planned, or an earlier amputation above the ankle of the study leg.
  • Cannot take any antiplatelet drug, or has a severe bleeding problem.
  • Active, uncontrolled, severe leg infection or blood infection.
  • Heart attack-type event or stroke within 30 days, severe kidney disease (eGFR<30 mL/min/1.73m2) or severe liver disease.
  • Pregnancy, breastfeeding, no effective birth control, or life expectancy <1 year.

A regiszter feltételei, szó szerint

Mind a 16 feltétel megnézéseKevesebb

Ki vehet részt

  • Age ≥18 years
  • Documented chronic limb-threatening ischemia, meeting the following criteria according to guidelines(13):; Presence of ischemic symptoms compatible with CLTI, defined as arterial insufficiency with gangrene, non-healing ischemic ulcer, or rest pain consistent with Rutherford classes 4-5 AND; Imaging evidence within the past 12 months showing atherosclerotic PAD, including CTA, MRA, angiography or duplex ultrasound AND; Ankle-Brachial Index (ABI) ≤0.80 or Toe-Brachial Index (TBI) ≤0.60 for patients who never underwent revascularization; ABI ≤0.85 or TBI ≤0.65 for those with history of prior revascularization procedures OR; Ischemic rest pain alone (Rutherford class 4) with ankle systolic pressure <50 mmHg, toe pressure of <30 mmHg, transcutaneous PO2 of <30 mmHg, or flat-line transtarsal pulse volume recording OR; Tissue loss with or without ischemic rest pain (Rutherford class 5) with ankle systolic pressure <70 mmHg, toe pressure of <50 mmHg, transcutaneous PO2 of <30 mmHg, or flatline transtarsal pulse volume recording
  • Absence of occlusive upstream disease, defined by the following:; Demonstrated vascular patency from the aorta to the second segment of the popliteal artery (P2), either by angiography, duplex ultrasound, CTA or MRA within the last 7 days prior to randomization; In patients who underwent prior treatment for upstream disease, there are no restrictions in treatment modalities received as long as patency is demonstrated as previously defined; If upstream disease is planned to be treated in the same index procedure, technically successful treatment of the upstream vessels must be achieved before randomization, defined as less than 30% residual stenosis and no flow-limiting dissections
  • Informed Consent:; Demonstrated ability and willingness to adhere to the study protocol and provide written informed consent

Ki nem vehet részt

  • Patient with a history of prior major (above-the-ankle) amputation of the study limb
  • Previous (within 30 days) or concomitant participation in another clinical study with investigational medicinal product(s) that has not yet reached its primary endpoint
  • Asymptomatic or mild disease: patients who underwent revascularization for disease graded Rutherford classes 0-3
  • Unable to tolerate any antiplatelet agent or with severe bleeding diathesis
  • Acute coronary syndrome or acute stroke within 30 days of screening
  • Active hepatitis or severe liver cirrhosis (Child Pugh C)
  • Clinical signs of active, uncontrolled, severe limb infection or septicemia, defined as fever exceeding 38.5°C, a white blood cell count above 15,000 cells/µL, or hypotension, at the time of screening (this does not include osteomyelitis confined to the phalanges or metatarsal heads or foot cellulitis treatable with IV antibiotics at the time of revascularization)
  • Advanced CKD (defined with eGFR<30 mL/min/1.73m2) or end-stage renal disease
  • Age <18 years
  • Patients with major tissue loss (Rutherford 6) in whom major amputation was planned at the time of screening
  • Pregnancy, breastfeeding, or women of childbearing potential who are not using an effective method of contraception
  • Life expectancy <1 year

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Chronic limb-threatening ischemia (CLTI) is a severe form of peripheral artery disease in which very poor blood flow in the arteries below the knee can cause rest pain, non-healing wounds, and even loss of the limb. It is often treated with endovascular therapy (EVT), a minimally invasive procedure that opens the blocked artery, but the artery frequently narrows or closes again afterward. These procedures are usually guided by X-ray pictures taken with dye (angiography). Intravascular ultrasound (IVUS) is an imaging tool that uses a small catheter inside the artery to give a more detailed view of the vessel, which may help doctors open it more completely. It is not yet clear whether adding IVUS improves results below the knee.

A teljes eredeti leírásKevesebb

This study is testing whether guiding treatment with IVUS plus angiography keeps the artery open better than angiography alone. Adults aged 18 or older with CLTI who are having endovascular therapy for a blocked artery below the knee may take part. Participants are assigned by chance to be treated with either both imaging methods or angiography alone, and are followed for 12 months. The main question is how well the treated artery stays open at 6 months; researchers will also compare repeat procedures, amputation, complications, wound healing, survival, and quality of life.

A vizsgálat 2 csoportja

  • IVUS + Angiography-guided EVTA vizsgált kezelés

    Kezelés: Intravascular ultrasound-guided EVT

  • Angiography-guided EVTMár használt kezelés, összehasonlításként

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Intravascular Ultrasound IMaging vs Angiography-Guided EVT in Below-the-Knee Arteries
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. július 28.